They identified the following risk factors for recurrence: African-American race, female sex, LETM at onset, anti-Ro antibody positivity, vitamin D insufficiency, ANA, and presence of inflammatory markers (IgG index) in the CSF. The gene discussed is BTG3; the disease is vitamin D deficiency.